InsidersTradesSigma
Follow the Novo Nordisk A/S stock price and the full insider trade history of the company, a listed issuer based in Denmark. Shares are quoted on the DK market, under the oversight of Finanstilsynet DK. Operating in the Health Care sector, Novo Nordisk A/S has published 207 public disclosures. The latest transaction was disclosed on 6 August 2026 (Other). Among the most active insiders: member/Executive/Associated Person. Every trade is openly available.
207
Insider Decl.
n/a
Thresholds
€4m
39 ops.
Buy Volume
€6bn
56 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 6 August 2026
Declarations207 total
74 shares@ DKK 294.30ShareOutside a trading venueISIN DK0062498333DK:1457096
50 shares@ DKK 294.2670.0% of flowShareOutside a trading venueISIN DK0062498333DK:1441704
26,246 shares@ DKK 315.600.0% of flowShareJANE STREET NETHERLANDS B.V.ISIN DK0062498333DK:1419574
22,000 shares@ DKK 319.800.0% of flowShareNasdaq CopenhagenISIN DK0062498333DK:1419156
1,085 shares0ShareOutside a trading venueISIN DK0062498333DK:1418330
6,450 shares@ DKK 312.500.0% of flowShareNasdaq CopenhagenISIN DK0062498333DK:1401014
18,634 shares0ShareOutside a trading venueISIN DK0062498333DK:1399962
952 shares@ DKK 349.060.0% of flowShareNew York Stock ExchangeDK:1384043
12,000 shares@ DKK 326.000.0% of flowShareNasdaq CopenhagenISIN DK0062498333DK:1382865
28,710 shares@ DKK 295.000.0% of flowShareNasdaq CopenhagenISIN DK0062498333DK:1382513
74 shares@ DKK 316.750.0% of flowShareCGETISIN DK0062498333DK:1382344
20,000 shares@ DKK 444.820.0% of flowShareNasdaq CopenhagenISIN DK0062498333DK:1362269
40,000 shares@ DKK 620.260.1% of flowShareNasdaq CopenhagenISIN DK0062498333DK:1341672
1,407 shares0ShareOutside a trading venueISIN DK0062498333DK:1341302
2,500 shares@ DKK 709.250.0% of flowShareNew York Stock ExchangeDK:1328724
1,300 shares@ DKK 743.310.0% of flowShareNew York Stock ExchangeDK:1327620
18,634 shares0ShareOutside a trading venueISIN DK0062498333DK:1327424
1,400 shares@ DKK 753.020.0% of flowShareNew York Stock ExchangeDK:1326827
1,400 shares@ DKK 697.240.0% of flowShareNew York Stock ExchangeDK:1326582
12.742 shares@ DKK 904.410.0% of flowShareNew York Stock ExchangeDK:1313875
2 shares@ DKK 913.15ShareNew York Stock ExchangeDK:1311855
8,480 shares@ DKK 895.500.0% of flowShareNasdaq CopenhagenISIN DK0062498333DK:1310732
11 shares@ DKK 891.200.0% of flowShareNasdaq CopenhagenISIN DK0062498333DK:1310299
208.385 shares@ DKK 819.720.0% of flowShareNew York Stock ExchangeDK:1310156
25 of 207 declarations
关于 Novo Nordisk A/S
Novo Nordisk A/S 是一家丹麦制药公司，专注于糖尿病和其他慢性疾病的治疗。该公司在哥本哈根证券交易所上市，股票代码为 NOVO。
